Australia markets closed

bluebird bio, Inc. (BLUE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.6058+0.0318 (+5.54%)
At close: 04:00PM EDT
0.6126 +0.01 (+1.12%)
After hours: 06:31PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
21,726
3,597
3,662
0
0
Cost of revenue
23,916
10,077
38,857
0
0
Gross profit
-2,190
-6,480
-35,195
0
0
Operating expenses
Research development
179,781
240,764
319,946
319,309
327,119
Selling general and administrative
149,113
136,908
209,969
239,950
235,844
Total operating expenses
133,964
275,672
529,915
559,259
562,963
Operating income or loss
-136,154
-282,152
-565,110
-559,259
-562,963
Total other income/expenses net
36,690
14,659
1,851
-6,881
-9,984
Income before tax
-91,137
-266,461
-562,380
-560,370
-555,567
Income tax expense
30
117
258
686
-545
Income from continuing operations
-91,167
-266,578
-562,638
-561,056
-555,022
Net income
-91,167
-266,578
-819,378
-618,695
-789,608
Net income available to common shareholders
-91,167
-266,578
-819,378
-618,695
-789,608
Basic EPS
-0.63
-3.39
-11.89
-9.95
-14.31
Diluted EPS
-0.63
-3.39
-11.89
-9.95
-14.31
Basic average shares
101,507
78,585
68,910
62,178
55,191
Diluted average shares
101,507
78,585
68,910
62,178
55,191